Amneal Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 1c
November 3, 2021 6:02 AM EDTAmneal Pharmaceuticals (: AMRX) reported Q3 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $529 million versus the consensus estimate of $544.49 million.
GUIDANCE:
Amneal Pharmaceuticals sees FY2021 EPS of $0.78-$0.88, versus the consensus of $0.88. Amneal... More
